954 Results for "

HDACs

" in MedChemExpress (MCE) Product Catalog:
Products (954)

954 Results for "HDACs" in MCE Product Catalog:

31
31 Cited Publications
Cat. No.: HY-15224
CAS No.: 950762-95-5
Purity:  99.84%
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

PCI-34051 is a potent and selective HDAC8 inhibitor with IC50 of 10 nM, with >200-fold selectivity over the other HDAC isoforms.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-12164
CAS No.: 726169-73-9
Purity:  99.13%
Synonyms: MGCD0103
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-13428
CAS No.: 537049-40-4
Purity:  99.54%
Research Areas:  

Cancer

Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1. Tubacin also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2).
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-N0931
CAS No.: 1477949-42-0
Synonyms: CAY-10683
Santacruzamate A (CAY-10683, STA) is a potent and selective HDAC2 inhibitor with an IC50 of 119 pM. STA also exerts neuroprotective property against amyloid-β protein fragment 25–35. STA can be used for cancer and neurological disease research .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-18360
CAS No.: 1314890-29-3
Target:  

HDAC

Research Areas:  

Cancer

TMP269 is a novel and selective class IIa histone deacetylase (HDAC) inhibitor with IC50s of 157 nM, 97 nM, 43 nM and 23 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-18361
CAS No.: 1314891-22-9
Target:  

HDAC

Research Areas:  

Cancer

TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor with Kis of 59, 60, 26, 15 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-100508
CAS No.: 200626-61-5
Purity:  99.73%
Target:  

HDAC

Research Areas:  

Cancer

ITSA-1 is an activator of histone deacetylase (HDAC), and counteract trichostatin A (TSA)-induced cell cycle arrest, histone acetylation, and transcriptional activation .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-10528
CAS No.: 254964-60-8
Purity:  99.94%
Synonyms: ABR-215050
Target:  

HDAC

Research Areas:  

Cancer

Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn 2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15433
CAS No.: 875320-29-9
Purity:  99.71%
Synonyms: JNJ-26481585
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat (JNJ-26481585) is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat has a broad spectrum antitumoral activity . Quisinostat can induce autophagy in neuroblastoma cells .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15433A
CAS No.: 875320-31-3
Purity:  99.05%
Synonyms: JNJ-26481585 dihydrochloride
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally active, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity. Quisinostat dihydrochloride can induce autophagy in neuroblastoma cells .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-B0246
CAS No.: 298-46-4
Synonyms: CBZ; NSC 169864
Carbamazepine is an orally active pressure-sensitive sodium ion channel blocker with an IC50 of 131 μM. Carbamazepine blocks voltage gated Na +, Ca 2+, and K + channels, and is also a HDAC inhibitor (IC50: 2 μM). Carbamazepine is an anticonvulsant and can be used for research of epilepsy and neuropathic pain .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13522
CAS No.: 1339928-25-4
Purity:  99.95%
Synonyms: CUDC-907
Target:  

PI3K HDAC Apoptosis

Research Areas:  

Cancer

Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of 19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3Kα/PI3Kβ/PI3Kδ and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-B0809
CAS No.: 58-55-9
Synonyms: 1,3-Dimethylxanthine; Theo-24
Theophylline (1,3-Dimethylxanthine) is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) induces apoptosis. Theophylline (1,3-Dimethylxanthine) can be used for asthma and chronic obstructive pulmonary disease (COPD) research .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-16425
CAS No.: 1215493-56-3
Synonyms: RGFP109
Target:  

HDAC

Research Areas:  

Cancer

RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842A
CAS No.: 199657-29-9
Purity:  98.06%
Synonyms: ITF-2357 hydrochloride
Target:  

HDAC

Research Areas:  

Inflammation/Immunology Cancer

Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride can penetrate the blood-brain barrier (BBB). .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842B
CAS No.: 732302-99-7
Purity:  98.06%
Synonyms: ITF-2357 hydrochloride monohydrate
Givinostat hydrochloride monohydrate (ITF-2357 hydrochloride monohydrate) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride monohydrate can penetrate the blood-brain barrier (BBB) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842
CAS No.: 497833-27-9
Purity:  98.67%
Synonyms: ITF-2357
Target:  

HDAC

Research Areas:  

Inflammation/Immunology Cancer

Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat can be used for Duchenne muscular dystrophy (DMD) research. Givinostat can penetrate the blood-brain barrier (BBB) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-B0809A
CAS No.: 5967-84-0
Synonyms: 1,3-Dimethylxanthine monohydrate; Theo-24 monohydrate
Theophylline (1,3-Dimethylxanthine) monohydrate is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) monohydrate inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) monohydrate has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) monohydrate induces apoptosis. Theophylline (1,3-Dimethylxanthine) monohydrate can be used for asthma and chronic obstructive pulmonary disease (COPD) research .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-50934
CAS No.: 112522-64-2
Synonyms: N-acetyldinaline; CI-994; Goe-5549
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Tacedinaline (N-acetyldinaline) is an inhibitor of the histone deacetylase (HDAC) with IC50s of 0.9, 0.9, 1.2 μM for recombinant HDAC 1, 2 and 3 respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-100871
CAS No.: 1206731-57-8
Purity:  98.36%
Research Areas:  

Cancer

WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of 0.40 nM . WT-161 also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2) .
loading...
    loading...